CEO: Italy-made Sputnik V aimed for EU market, if approved

The head of a Swiss pharmaceutical company said hopes behind a deal with Russia to produce the Sputnik V vaccine in Italy are to sell it in the European Union, but several hurdles must first be overcome

Related posts